Advertisement
Screener

GSK plc (GLAXF) Form 6-K: Report of foreign private issuer, 2013, Page 2

2.1 / 5 stars · 17/40 Roast Me

Add as a preferred source on Google

GSK plc Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2013-09-17: Form 6-K; Period of report 2013-09-17; Description TRANSACTION IN OWN SHARES; Document gsk201309176k.htm.
  • 2013-09-16: Form 6-K; Period of report 2013-09-16; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201309166k2.htm.
  • 2013-09-16: Form 6-K; Period of report 2013-09-16; Description TRANSACTION IN OWN SHARES; Document gsk201309166k1.htm.
  • 2013-09-16: Form 6-K; Period of report 2013-09-16; Description DABRAFENIB/TRAMETINIB COMBO - FDA PRIORITY REVIEW; Document gsk201309166k.htm.
FiledFormPeriod of reportDescriptionDocument
2013-09-176-K2013-09-17TRANSACTION IN OWN SHARESgsk201309176k.htm
2013-09-166-K2013-09-16DIRECTOR/PDMR SHAREHOLDINGgsk201309166k2.htm
2013-09-166-K2013-09-16TRANSACTION IN OWN SHARESgsk201309166k1.htm
2013-09-166-K2013-09-16DABRAFENIB/TRAMETINIB COMBO - FDA PRIORITY REVIEWgsk201309166k.htm
2013-09-136-K2013-09-13TRANSACTION IN OWN SHARESgsk201309136k.htm
2013-09-126-K2013-09-12TRANSACTION IN OWN SHARESgsk201309126k.htm
2013-09-116-K2013-09-11TRANSACTION IN OWN SHARESgsk201309116k3.htm
2013-09-116-K2013-09-11DIRECTOR/PDMR SHAREHOLDINGgsk201309116k2.htm
2013-09-116-K2013-09-11DIRECTOR/PDMR SHAREHOLDINGgsk201309116k1.htm
2013-09-116-K2013-09-11FDA ADCOM RECOMMENDS ANORO ELLIPTA (UMEC/VI)gsk201309116k.htm
2013-09-096-K2013-09-09GSK TO DIVEST LUCOZADE AND RIBENA FOR ?1.35BNgsk201309096k.htm
2013-09-056-K2013-09-05MAGE A-3 PHASE III DERMA STUDY RESULTSgsk201309056k.htm
2013-09-046-K2013-09-02DIRECTOR/PDMR SHAREHOLDINGgsk201309046k.htm
2013-09-036-K2013-09-03TRANSACTION IN OWN SHARESgsk201309026k1.htm
2013-09-036-K2013-09-03TOTAL VOTING RIGHTSgsk201309026k.htm
2013-08-306-K2013-08-30TRANSACTION IN OWN SHARESgsk201308306k.htm
2013-08-296-K2013-08-29TRANSACTION IN OWN SHARESgsk201308296k.htm
2013-08-286-K2013-08-28TRANSACTION IN OWN SHARESgsk201308286k2.htm
2013-08-286-K2013-08-28DIRECTOR/PDMR SHAREHOLDINGgsk201308286k1.htm
2013-08-286-K2013-08-27DIRECTOR/PDMR SHAREHOLDINGgsk201308286k.htm
2013-08-276-K2013-08-27TRANSACTION IN OWN SHARESgsk201308276k.htm
2013-08-236-K2013-08-23TRANSACTION IN OWN SHARESgsk201308236k.htm
2013-08-226-K2013-08-22TRANSACTION IN OWN SHARESgsk201308226k.htm
2013-08-216-K2013-08-21TRANSACTION IN OWN SHARESgsk201308216k.htm
2013-08-206-K2013-08-19TRANSACTION IN OWN SHARESgsk201308206k.htm
2013-08-196-K2013-08-19DIRECTOR/PDMR SHAREHOLDINGgsk201308196k.htm
2013-08-166-K2013-08-16TRANSACTION IN OWN SHARESgsk201308166k.htm
2013-08-156-K2013-08-15TRANSACTION IN OWN SHARESgsk201308156k1.htm
2013-08-146-K2013-08-13TRANSACTION IN OWN SHARESgsk201308156k.htm
2013-08-136-K2013-08-13TIVICAY (R) (DOLUTEGRAVIR) RECEIVES FDA APPROVALgsk201308136k.htm
2013-08-126-K2013-08-12TRANSACTION IN OWN SHARESgsk201308126k3.htm
2013-08-126-K2013-08-12DIRECTOR/PDMR SHAREHOLDINGgsk201308126k2.htm
2013-08-126-K2013-08-12DIRECTOR/PDMR SHAREHOLDINGgsk201308126k1.htm
2013-08-126-K2013-08-12DIRECTOR/PDMR SHAREHOLDINGgsk201308126k.htm
2013-08-096-K2013-08-09TRANSACTION IN OWN SHARESgsk201308096k.htm
2013-08-086-K2013-08-08TRANSACTION IN OWN SHARESgsk201308086k.htm
2013-08-076-K2013-08-07TRANSACTION IN OWN SHARESgsk201308076k.htm
2013-08-066-K2013-08-06TRANSACTION IN OWN SHARESgsk201308066k2.htm
2013-08-066-K2013-08-06DIRECTOR/PDMR SHAREHOLDINGgsk201308066k.htm
2013-08-056-K2013-08-05DIRECTOR/PDMR SHAREHOLDINGgsk201308056k.htm
2013-08-026-K2013-08-01TRANSACTION IN OWN SHARESgsk201308026k2.htm
2013-08-026-K2013-08-02REGULATORY UPDATE - ALBIGLUTIDEgsk201308026k.htm
2013-08-016-K2013-08-01TRANSACTION IN OWN SHARESgsk201308016k1.htm
2013-08-016-K2013-08-01TOTAL VOTING RIGHTSgsk201308016k.htm
2013-07-316-K2013-07-31TRANSACTION IN OWN SHARESgsk201307316k1.htm
2013-07-316-K2013-07-31DIRECTOR/PDMR SHAREHOLDINGgsk201307316k.htm
2013-07-246-K2013-07-24HALF YEARLY REPORTgsk201307246k.htm
2013-07-236-K2013-07-23TRANSACTION IN OWN SHARESgsk201307236k.htm
2013-07-226-K2013-07-22TRANSACTION IN OWN SHARESgsk201307226k4.htm
2013-07-226-K2013-07-22DIRECTOR/PDMR SHAREHOLDINGgsk201307226k3.htm
2013-07-226-K2013-07-22DIRECTOR/PDMR SHAREHOLDINGgsk201307226k2.htm
2013-07-226-K2013-07-22GSK CONSUMER NIGERIA PLC SCH OF ARRANGEMENT UPDATEgsk201307226k.htm
2013-07-196-K2013-07-19DIRECTOR/PDMR SHAREHOLDINGgsk201307196k2.htm
2013-07-196-K2013-07-19DIRECTOR/PDMR SHAREHOLDINGgsk201307196k1.htm
2013-07-196-K2013-07-19DIRECTOR/PDMR SHAREHOLDINGgsk201307196k.htm
2013-07-186-K2013-07-18DIRECTOR/PDMR SHAREHOLDINGgsk201307186k.htm
2013-07-176-K2013-07-17DIRECTOR/PDMR SHAREHOLDINGgsk201307176k2.htm
2013-07-176-K2013-07-17DIRECTOR/PDMR SHAREHOLDINGgsk201307176k1.htm
2013-07-176-K2013-07-17DIRECTOR/PDMR SHAREHOLDINGgsk201307176k.htm
2013-07-166-K2013-07-16DIRECTOR/PDMR SHAREHOLDINGgsk201307166k1.htm
2013-07-166-K2013-07-16DIRECTOR/PDMR SHAREHOLDINGgsk201307166k.htm
2013-07-126-K2013-07-12DIRECTOR/PDMR SHAREHOLDINGgsk201307126k2.htm
2013-07-126-K2013-07-10DIRECTOR/PDMR SHAREHOLDINGgsk201307126k1.htm
2013-07-126-K2013-07-10DIRECTOR/PDMR SHAREHOLDINGgsk201307126k.htm
2013-07-116-K2013-07-11DIRECTOR/PDMR SHAREHOLDINGgsk201307116k2.htm
2013-07-116-K2013-07-11DIRECTOR/PDMR SHAREHOLDINGgsk201307116k1.htm
2013-07-116-K2013-07-11HOLDING(S) IN COMPANYgsk201307116k.htm
2013-07-106-K2013-07-10DIRECTOR/PDMR SHAREHOLDINGgsk201307106k.htm
2013-07-106-K2013-07-10DIRECTOR/PDMR SHAREHOLDINGgsk201307106k1.htm
2013-07-096-K2013-07-09DIRECTOR/PDMR SHAREHOLDINGgsk201307096k3.htm
2013-07-096-K2013-07-09DIRECTOR/PDMR SHAREHOLDINGgsk201307096k2.htm
2013-07-096-K2013-07-09US SUBMISSION FOR BRAF/MEK COMBINATION THERAPYgsk201307096k.htm
2013-07-056-K2013-07-04TRANSACTION IN OWN SHARESgsk201307046k.htm
2013-07-036-K2013-07-03DIRECTOR/PDMR SHAREHOLDINGgsk201307036k1.htm
2013-07-036-K2013-07-03TRANSACTION IN OWN SHARESgsk201307036k.htm
2013-07-026-K2013-07-02TRANSACTION IN OWN SHARESgsk201307026k.htm
2013-07-016-K2013-07-01DIRECTOR/PDMR SHAREHOLDINGgsk201307016k6.htm
2013-07-016-K2013-07-01DIRECTOR/PDMR SHAREHOLDINGgsk201307016k5.htm
2013-07-016-K2013-07-01DIRECTOR/PDMR SHAREHOLDINGgsk201307016k4.htm
2013-07-016-K2013-07-01TRANSACTION IN OWN SHARESgsk201307016k3.htm
2013-07-016-K2013-07-01DIRECTOR/PDMR SHAREHOLDINGgsk201307016k2.htm
2013-07-016-K2013-07-01TOTAL VOTING RIGHTSgsk201307016k.htm
2013-06-286-K2013-06-28SHARE BUY-BACK PROGRAMME DURING CLOSE PERIODgsk201306286k1.htm
2013-06-286-K2013-06-28TRANSACTION IN OWN SHARESgsk201306286k.htm
2013-06-276-K2013-06-27TRANSACTION IN OWN SHARESgsk201306276k.htm
2013-06-266-K2013-06-26TRANSACTION IN OWN SHARESgsk201306266k.htm
2013-06-256-K2013-06-25TRANSACTION IN OWN SHARESgsk201306256k.htm
2013-06-246-K2013-06-24TRANSACTION IN OWN SHARESgsk201306246k2.htm
2013-06-246-K2013-06-24DIRECTOR/PDMR SHAREHOLDINGgsk201306246k1.htm
2013-06-246-K2013-06-24ALBIGLUTIDE-DATA FROM FIVE PHASE III STUDIESgsk201306246k.htm
2013-06-216-K2013-06-21TRANSACTION IN OWN SHARESgsk201306216k.htm
2013-06-206-K2013-06-20TRANSACTION IN OWN SHARESgsk201306206k1.htm
2013-06-206-K2013-06-20DIRECTOR/PDMR SHAREHOLDINGgsk201306206k.htm
2013-06-196-K2013-06-19TRANSACTION IN OWN SHARESgsk201306196k.htm
2013-06-186-K2013-06-18TRANSACTION IN OWN SHARESgsk201306186k1.htm
2013-06-186-K2013-06-17GSK RECEIVES OFFER FOR THROMBOSIS BRANDSgsk201306186k.htm
2013-06-176-K2013-06-17TRANSACTION IN OWN SHARESgsk201306176k.htm
2013-06-146-K2013-06-14TRANSACTION IN OWN SHARESgsk201306146k.htm
2013-06-136-K2013-06-12TRANSACTION IN OWN SHARESgsk201306136k.htm
2013-06-126-K2013-06-12TRANSACTION IN OWN SHARESgsk201306126k2.htm
Advertisement